The cleaning validation is the most important step. Cleaning validation is a crucial aspect of pharmaceutical manufacturing to ensure that residues from previous batches do not contaminate subsequent products. This review explores the principles, regulatory requirements, analytical techniques, validation parameters, challenges, and future trends associated with cleaning validation. The focus is on ensuring compliance with Good Manufacturing Practices (GMP) while maintaining product safety and efficacy. This review paper provides a comprehensive review of analytical method cleaning validation procedures.
References
[1]
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2000) ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. ICH.
[2]
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2009) ICH Q8 (R2): Pharmaceutical Development. ICH.
[3]
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2023) ICH Q9 (R1): Quality Risk Management. ICH.
[4]
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2008) ICH Q10: Pharmaceutical Quality System. ICH.
[5]
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2012) ICH Q11: Development and Manufacture of Drug Substances (Chemical and Biotechnological/Biological Entities). ICH.
[6]
U.S. Food and Drug Administration (1993) Guide to Inspections of Validation of Cleaning Processes. FDA.
[7]
Fourman, G.L. and Mullen, M.V. (1993) Determining Cleaning Validation Acceptance Limits for Pharmaceutical Manufacturing Operations. Pharmaceutical Technology, 17, 54-60.
[8]
Parenteral Drug Association (2012) Technical Report No. 29 (Revised): Points to Consider for Cleaning Validation. PDA.
[9]
International Society for Pharmaceutical Engineering (2010) Baseline® Guide, Volume 7: Risk-Based Manufacture of Pharmaceutical Products. ISPE.
[10]
World Health Organization (WHO) (2014) Good Manufacturing Practices for Pharmaceutical Products. WHO.
U.S. Food and Drug Administration (2011) Process Validation: General Principles and Practices. Guidance for Industry. FDA.
[14]
International Society for Pharmaceutical Engineering (2020) ISPE Guide: Cleaning Validation Lifecycle—Applications, Methods, and Controls. ISPE.
[15]
Reddy, R., Kumar, S. and Rao, B. (2022) Life Cycle Approach to Cleaning Validation. International Journal of Pharmaceutical Sciences and Research, 13, 4580-4592.
[16]
Bader, K., et al. (2009) Cleaning Validation: A Life Cycle Approach. Pharmaceutical Engineering, 29, 8-20.
[17]
U.S. Food and Drug Administration (2025) 21 CFR 211.67: Equipment Cleaning and Maintenance. Code of Federal Regulations, Title 21. U.S. Government Publishing Office.
[18]
U.S. Food and Drug Administration (2014) Validation of Cleaning Processes (7/93). Guide to Inspections. FDA.
[19]
ValGenesis (2025) Why Cleaning Validation Still Tops FDA 483 Observations. ValGenesis Blog.
[20]
ECA Academy (2025) FDA Takes a Look at Cleaning Validation. ECA GMP News, 19 March 2025.
[21]
Leucine (2024) Essential Insights on Cleaning Validation FDA Guidance for Compliance. Leucine Blog, 20 November 2024.
[22]
U.S. Food and Drug Administration (2025) Inspection Observations: FY 2024. FDA Official Resource, 5 June 2025.
[23]
Rathore, A.S., Li, Y., Chhabra, H. and Lohiya, A. (2022) Validation-Related Violations in FDA Warning Letters. Journal of Pharmaceutical Innovation, 17, 845-852.
[24]
Simmonds, E.L., Lough, W.J. and Gray, M.R. (2006) Evaluation of LC-MS for the Analysis of Cleaning Verification Samples. Journal of Pharmaceutical and Biomedical Analysis, 40, 631-638. https://doi.org/10.1016/j.jpba.2005.10.026
[25]
Vaghela, U. (2025) Comparative Evaluation of High-Performance Liquid Chromatography versus Total Organic Carbon Analysis for Cleaning Validation in Pharmaceutical Manufacturing.
[26]
Li, X., Ahmad, I.A.H., Tam, J., Wang, Y., Dao, G. and Blasko, A. (2018) Cleaning Verification: A Five Parameter Study of a TOC Method Development and Validation for the Cleaning Assessment of Residual Detergents in Manufacturing Equipment. Journal of Pharmaceutical and Biomedical Analysis, 149, 33-39. https://doi.org/10.1016/j.jpba.2017.10.021
[27]
Jul-Jørgensen, I., Hundahl, C.A., Skibsted, E. and Gernaey, K.V. (2022) Sampling Error of TOC Swab in Pharmaceutical Cleaning Verification. Journal of Pharmaceutical and Biomedical Analysis, 215, Article 114763. https://doi.org/10.1016/j.jpba.2022.114763
[28]
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2023) ICH Q2 (R2): Validation of Analytical Procedures. ICH, Geneva. (Revised Guideline Adopted November 2023).
[29]
Zayas, J., Colón, H., Garced, O. and Ramos, L.M. (2006) Cleaning Validation 1: Development and Validation of a Chromatographic Method for the Detection of Traces of LpHse Detergent. Journal of Pharmaceutical and Biomedical Analysis, 41, 589-593. https://doi.org/10.1016/j.jpba.2005.10.049
[30]
Schmidt, A.H. (2006) Validated HPLC Method for the Determination of Residues of Acetaminophen, Caffeine, and Codeine Phosphate. Journal of Liquid Chromatography & Related Technologies, 29, 1663-1673. https://doi.org/10.1080/10826070600678381
[31]
Fazio, T.T., Singh, A.K., Kedor-Hackmann, E.R.M. and Santoro, M.I.R.M. (2007) Quantitative Determination and Sampling of Azathioprine Residues for Cleaning Validation in Production Area. Journal of Pharmaceutical and Biomedical Analysis, 43, 1495-1498. https://doi.org/10.1016/j.jpba.2006.10.016
[32]
Milenović, D.M., Lazić, M.L., Veljković, V.V. and Todorović, Z.T. (2008) Validation of an HPLC Method for Analysis of Nifedipine Residues on Stainless-Steel Surfaces in the Manufacture of Pharmaceuticals. Acta Chromatographica, 20, 183-194. https://doi.org/10.1556/achrom.20.2008.2.4
[33]
Fekete, S., Fekete, J. and Ganzler, K. (2009) Validated UPLC Method for the Fast and Sensitive Determination of Steroid Residues in Support of Cleaning Validation in Formulation Area. Journal of Pharmaceutical and Biomedical Analysis, 49, 833-838. https://doi.org/10.1016/j.jpba.2008.12.027
[34]
Akl, M.A., Ahmed, M.A. and Ramadan, A. (2011) Validation of an HPLC-UV Method for the Determination of Ceftriaxone Sodium Residues on Stainless Steel Surface of Pharmaceutical Manufacturing Equipments. Journal of Pharmaceutical and Biomedical Analysis, 55, 247-252. https://doi.org/10.1016/j.jpba.2011.01.020
[35]
Coelho, A.S., Arribada, R.G. and Lages, E.B. (2020) Cleaning Validation for Residual Estimation of Mometasone Furoate on Stainless-Steel Surface Using UHPLC-UV Method. PDA Journal of Pharmaceutical Science and Technology, 74, 185-197.
[36]
Nozal, M.J., Bernal, J.L., Toribio, L., Martín, M.T. and Diez, F.J. (2002) Development of an LC Assay for Sumatriptan Succinate Residues on Surfaces in Pharmaceutical Manufacture. Journal of Pharmaceutical and Biomedical Analysis, 30, 285-291.
[37]
Kaleswararao, T. and Suryakala, D. (2021) RP-HPLC Method Development and Validation for Cleaning Residue Determination of Tofacitinib Citrate in Tofacitinib Tablets. Journal of Pharmaceutical Research International, 33, 262-276. https://doi.org/10.9734/jpri/2021/v33i51b33541
[38]
Tanyous, J.N. (2019) Cleaning Validation: Complete Guide for Health—Based Approach in Chemical Cross—Contamination Risk Assessment. PDA Journal of Pharmaceutical Science and Technology, 73, 204-210. https://doi.org/10.5731/pdajpst.2018.008946
[39]
Weideman, P.A., Pecquet, A.M. and Maier, M.A. (2016) Harmonization Efforts for Deriving Health-Based Exposure Limits in the Pharmaceutical Industry—Advancing the Current Science and Practice. Regulatory Toxicology and Pharmacology, 79, S1-S2. https://doi.org/10.1016/j.yrtph.2016.07.016
[40]
World Health Organization (2021) WHO Technical Report Series No. 1033: Points to Consider When Including Health-Based Exposure Limits (HBELs) in Cleaning Validation. WHO.
